Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

Corticosteroids and unraveling the spectrum of differentiation syndromes in AML

Justin Watts, MD, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, discusses the role of corticosteroids in managing differentiation syndrome (DS) in acute myeloid leukemia (AML), highlighting their effectiveness in ameliorating cytokine release syndrome (CRS), capillary leak syndrome (CLS), and organ damage. Dr Watts emphasizes the importance of using steroids early and at a sufficient dose, as well as the need for better cytoreduction strategies, particularly for monocytic AML, and the potential for developing better models to study DS. This presentation took place at the 8th International Workshop on Acute Leukemias (iwAL) in Cambridge, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.